US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist

0.890
+0.040+4.71%

Close Nov 29 13:00 ET

0.910
+0.020+2.25%

Post 17:01 ET

58.63MMarket Cap-689P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

12.86%26.5M

-1.46%21.53M

12.68%20.2M

28.03%91.44M

38.23%28.18M

48.02%23.48M

20.32%21.85M

5.37%17.92M

73.22%71.42M

-4.70%20.39M

Selling and administrative expenses

8.53%6.33M

6.30%5.69M

-2.29%5.89M

-3.37%23.61M

7.67%6.41M

-0.24%5.83M

-9.89%5.35M

-10.14%6.02M

120.52%24.44M

20.20%5.96M

-General and administrative expense

8.53%6.33M

6.30%5.69M

-2.29%5.89M

-3.37%23.61M

7.67%6.41M

-0.24%5.83M

-9.89%5.35M

-10.14%6.02M

120.52%24.44M

20.20%5.96M

Research and development costs

14.29%20.18M

-3.97%15.85M

20.26%14.31M

44.36%67.83M

50.83%21.77M

76.16%17.66M

34.99%16.5M

15.47%11.9M

55.83%46.99M

-12.21%14.43M

Operating profit

-12.86%-26.5M

1.46%-21.53M

-12.68%-20.2M

-28.03%-91.44M

-38.23%-28.18M

-48.02%-23.48M

-20.32%-21.85M

-5.37%-17.92M

-73.22%-71.42M

4.70%-20.39M

Net non-operating interest income expense

-37.47%1.07M

9.62%1.31M

57.30%1.62M

430.30%5.88M

148.91%1.95M

350.66%1.71M

2,035.71%1.2M

1,051.85%1.03M

407.20%1.11M

618.54%783K

Non-operating interest income

-37.47%1.07M

9.62%1.31M

57.30%1.62M

316.80%5.88M

149.87%1.95M

273.74%1.71M

656.96%1.2M

6,753.33%1.03M

--1.41M

--780K

Non-operating interest expense

----

--0

----

-16.34%302K

-101.99%-3K

Other net income (expense)

576.61%1.63M

-1,000.00%-90K

-279.07%-462K

154.62%331K

-22.41%405K

-293.10%-342K

103.50%10K

1,390.00%258K

100.50%130K

71.15%522K

Gain on sale of security

576.61%1.63M

-1,000.00%-90K

-279.07%-462K

154.62%331K

-22.41%405K

-293.10%-342K

103.50%10K

1,390.00%258K

-59.25%130K

5,120.00%522K

Income before tax

-7.63%-23.81M

1.62%-20.31M

-14.45%-19.04M

-21.44%-85.23M

-35.34%-25.83M

-42.03%-22.12M

-12.26%-20.65M

2.92%-16.64M

-3.50%-70.19M

10.15%-19.08M

Income tax

147.61%209K

-29.70%374K

2.22%415K

-33.07%852K

-64.24%353K

-481.74%-439K

411.54%532K

515.15%406K

1,772.06%1.27M

1,351.47%987K

Net income

-10.78%-24.02M

2.32%-20.69M

-14.16%-19.46M

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

-5.27%-71.46M

5.81%-20.07M

Net income continuous Operations

-10.78%-24.02M

2.32%-20.69M

-14.16%-19.46M

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

-5.27%-71.46M

5.81%-20.07M

Minority interest income

Net income attributable to the parent company

-10.78%-24.02M

2.32%-20.69M

-14.16%-19.46M

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

-5.27%-71.46M

5.81%-20.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-10.78%-24.02M

2.32%-20.69M

-14.16%-19.46M

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

4.71%-71.46M

10.44%-20.07M

Basic earnings per share

16.28%-0.36

58.11%-0.31

49.15%-0.3

20.16%-1.98

43.23%-0.3974

20.37%-0.43

-15.63%-0.74

1.67%-0.59

85.66%-2.48

10.00%-0.7

Diluted earnings per share

16.28%-0.36

58.11%-0.31

49.15%-0.3

20.16%-1.98

43.23%-0.3974

20.37%-0.43

-15.63%-0.74

1.67%-0.59

85.66%-2.48

10.00%-0.7

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	12.86%26.5M	-1.46%21.53M	12.68%20.2M	28.03%91.44M	38.23%28.18M	48.02%23.48M	20.32%21.85M	5.37%17.92M	73.22%71.42M	-4.70%20.39M
Selling and administrative expenses	8.53%6.33M	6.30%5.69M	-2.29%5.89M	-3.37%23.61M	7.67%6.41M	-0.24%5.83M	-9.89%5.35M	-10.14%6.02M	120.52%24.44M	20.20%5.96M
-General and administrative expense	8.53%6.33M	6.30%5.69M	-2.29%5.89M	-3.37%23.61M	7.67%6.41M	-0.24%5.83M	-9.89%5.35M	-10.14%6.02M	120.52%24.44M	20.20%5.96M
Research and development costs	14.29%20.18M	-3.97%15.85M	20.26%14.31M	44.36%67.83M	50.83%21.77M	76.16%17.66M	34.99%16.5M	15.47%11.9M	55.83%46.99M	-12.21%14.43M
Operating profit	-12.86%-26.5M	1.46%-21.53M	-12.68%-20.2M	-28.03%-91.44M	-38.23%-28.18M	-48.02%-23.48M	-20.32%-21.85M	-5.37%-17.92M	-73.22%-71.42M	4.70%-20.39M
Net non-operating interest income expense	-37.47%1.07M	9.62%1.31M	57.30%1.62M	430.30%5.88M	148.91%1.95M	350.66%1.71M	2,035.71%1.2M	1,051.85%1.03M	407.20%1.11M	618.54%783K
Non-operating interest income	-37.47%1.07M	9.62%1.31M	57.30%1.62M	316.80%5.88M	149.87%1.95M	273.74%1.71M	656.96%1.2M	6,753.33%1.03M	--1.41M	--780K
Non-operating interest expense	----	----	----	--0	----	----	----	----	-16.34%302K	-101.99%-3K
Other net income (expense)	576.61%1.63M	-1,000.00%-90K	-279.07%-462K	154.62%331K	-22.41%405K	-293.10%-342K	103.50%10K	1,390.00%258K	100.50%130K	71.15%522K
Gain on sale of security	576.61%1.63M	-1,000.00%-90K	-279.07%-462K	154.62%331K	-22.41%405K	-293.10%-342K	103.50%10K	1,390.00%258K	-59.25%130K	5,120.00%522K
Income before tax	-7.63%-23.81M	1.62%-20.31M	-14.45%-19.04M	-21.44%-85.23M	-35.34%-25.83M	-42.03%-22.12M	-12.26%-20.65M	2.92%-16.64M	-3.50%-70.19M	10.15%-19.08M
Income tax	147.61%209K	-29.70%374K	2.22%415K	-33.07%852K	-64.24%353K	-481.74%-439K	411.54%532K	515.15%406K	1,772.06%1.27M	1,351.47%987K
Net income	-10.78%-24.02M	2.32%-20.69M	-14.16%-19.46M	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	-5.27%-71.46M	5.81%-20.07M
Net income continuous Operations	-10.78%-24.02M	2.32%-20.69M	-14.16%-19.46M	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	-5.27%-71.46M	5.81%-20.07M
Minority interest income
Net income attributable to the parent company	-10.78%-24.02M	2.32%-20.69M	-14.16%-19.46M	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	-5.27%-71.46M	5.81%-20.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-10.78%-24.02M	2.32%-20.69M	-14.16%-19.46M	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	4.71%-71.46M	10.44%-20.07M
Basic earnings per share	16.28%-0.36	58.11%-0.31	49.15%-0.3	20.16%-1.98	43.23%-0.3974	20.37%-0.43	-15.63%-0.74	1.67%-0.59	85.66%-2.48	10.00%-0.7
Diluted earnings per share	16.28%-0.36	58.11%-0.31	49.15%-0.3	20.16%-1.98	43.23%-0.3974	20.37%-0.43	-15.63%-0.74	1.67%-0.59	85.66%-2.48	10.00%-0.7
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data